Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c563 |
|---|---|
| Identifier | NCT05119140 |
| Trial Title | Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (Disorder) |
| Interventions | DRUG: Hydroxychloroquine|DRUG: Mesalamine |
Participant Information
| Sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| City | Atlanta |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2022-06-10 |
|---|---|
| Primary Completion Date | 2025-05-25 |
| Completion Date | 2025-05-25 |